4-(4-(2-(4-(2,2-dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

ID: ALA1091984

PubChem CID: 46884578

Max Phase: Preclinical

Molecular Formula: C22H27N3

Molecular Weight: 333.48

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCC(C)(C)Cc1c[nH]c(CCc2ccc(-c3ccncc3)cc2)n1

Standard InChI:  InChI=1S/C22H27N3/c1-4-22(2,3)15-20-16-24-21(25-20)10-7-17-5-8-18(9-6-17)19-11-13-23-14-12-19/h5-6,8-9,11-14,16H,4,7,10,15H2,1-3H3,(H,24,25)

Standard InChI Key:  MWYNMVOIARFUJK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   11.0402  -22.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0391  -23.8023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7539  -24.2152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4703  -23.8019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4675  -22.9713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7521  -22.5622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3262  -24.2145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6118  -23.7998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8975  -24.2110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8964  -25.0369    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6155  -25.4498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3269  -25.0362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1804  -22.5561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8964  -22.9659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6093  -22.5508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3617  -22.8865    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9115  -22.2709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4962  -21.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6899  -21.7330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.7364  -22.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1451  -21.5499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9701  -21.5455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3788  -20.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3167  -21.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3542  -20.7458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  7  1  0
  6  1  1  0
  5 13  1  0
  1  2  2  0
 13 14  1  0
  3  4  2  0
 14 15  1  0
 15 16  2  0
  7  8  2  0
  8  9  1  0
  4  5  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 15  1  0
  9 10  2  0
 17 20  1  0
  2  3  1  0
 20 21  1  0
 10 11  1  0
 21 22  1  0
  5  6  2  0
 22 23  1  0
 11 12  2  0
 21 24  1  0
 12  7  1  0
 21 25  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1091984

   4-(4-(2-(4-(2,2-dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 333.48

Molecular Weight (Monoisotopic): 333.2205

AlogP: 5.24

#Rotatable Bonds: 7

Polar Surface Area: 41.57

Molecular Species: NEUTRAL

HBA: 2

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 7.14

CX LogP: 4.99

CX LogD: 4.81

Aromatic Rings: 3

Heavy Atoms: 25

QED Weighted: 0.64

Np Likeness Score: -0.54

References

1. Liu J, He S, Jian T, Dobbelaar PH, Sebhat IK, Lin LS, Goodman A, Guo C, Guzzo PR, Hadden M, Henderson AJ, Pattamana K, Ruenz M, Sargent BJ, Swenson B, Yet L, Tamvakopoulos C, Peng Q, Pan J, Kan Y, Palyha O, Kelly TM, Guan XM, Howard AD, Marsh DJ, Metzger JM, Reitman ML, Wyvratt MJ, Nargund RP..  (2010)  Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.,  20  (7): [PMID:20219372] [10.1016/j.bmcl.2010.02.076]

Source

Source(1):

• Scientific Literature